HUP0105391A3 - Immunogenic liposome compositions - Google Patents
Immunogenic liposome compositionsInfo
- Publication number
- HUP0105391A3 HUP0105391A3 HU0105391A HUP0105391A HUP0105391A3 HU P0105391 A3 HUP0105391 A3 HU P0105391A3 HU 0105391 A HU0105391 A HU 0105391A HU P0105391 A HUP0105391 A HU P0105391A HU P0105391 A3 HUP0105391 A3 HU P0105391A3
- Authority
- HU
- Hungary
- Prior art keywords
- liposome compositions
- immunogenic liposome
- immunogenic
- compositions
- liposome
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 239000002502 liposome Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10135198P | 1998-09-22 | 1998-09-22 | |
| US40072399A | 1999-09-21 | 1999-09-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0105391A2 HUP0105391A2 (hu) | 2002-05-29 |
| HUP0105391A3 true HUP0105391A3 (en) | 2006-02-28 |
Family
ID=26798150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0105391A HUP0105391A3 (en) | 1998-09-22 | 1999-09-22 | Immunogenic liposome compositions |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1115382B1 (hu) |
| JP (1) | JP2002526436A (hu) |
| KR (1) | KR100592825B1 (hu) |
| CN (1) | CN1555254A (hu) |
| AP (1) | AP2010A (hu) |
| AT (1) | ATE468108T1 (hu) |
| AU (1) | AU766772B2 (hu) |
| BG (1) | BG65675B1 (hu) |
| BR (1) | BR9914004A (hu) |
| CA (1) | CA2344173C (hu) |
| CY (1) | CY1110718T1 (hu) |
| CZ (1) | CZ20011013A3 (hu) |
| DE (1) | DE69942393D1 (hu) |
| DK (1) | DK1115382T3 (hu) |
| EA (1) | EA004797B1 (hu) |
| EE (1) | EE200100168A (hu) |
| ES (1) | ES2345695T3 (hu) |
| GE (1) | GEP20053444B (hu) |
| HK (1) | HK1039064A1 (hu) |
| HU (1) | HUP0105391A3 (hu) |
| ID (1) | ID29082A (hu) |
| IL (2) | IL141675A0 (hu) |
| MX (1) | MXPA01002973A (hu) |
| NO (1) | NO330685B1 (hu) |
| NZ (2) | NZ510442A (hu) |
| OA (1) | OA11657A (hu) |
| PL (1) | PL206260B1 (hu) |
| SK (1) | SK287670B6 (hu) |
| UA (1) | UA75327C2 (hu) |
| WO (1) | WO2000016746A2 (hu) |
| ZA (1) | ZA200101829B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006110831A2 (en) | 2005-04-12 | 2006-10-19 | Duke University | Method of inducing neutralizing antibodies to human immunodeficiency virus |
| CA2764424C (en) | 2009-06-04 | 2019-12-31 | National Institute Of Advanced Industrial Science And Technology | Vaccine for mycoplasma infection |
| JP2014518620A (ja) | 2011-04-26 | 2014-08-07 | モレキュラー エクスプレス，インコーポレイテッド | リポソーム製剤 |
| US10076567B2 (en) | 2013-09-27 | 2018-09-18 | Duke University | MPER-liposome conjugates and uses thereof |
| JP2020515629A (ja) * | 2017-04-04 | 2020-05-28 | アヴィディア テクノロジーズ， インコーポレイテッド | 免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用 |
| KR20240033309A (ko) * | 2022-09-05 | 2024-03-12 | 주식회사 차백신연구소 | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8405493D0 (sv) * | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| SE462375B (sv) * | 1985-10-15 | 1990-06-18 | Morgaardshammar Ab Centro | Traadblock |
| US4861597A (en) * | 1986-05-20 | 1989-08-29 | Wako Pure Chemical Industries, Ltd. | Novel functionallized liposomes and a process for production thereof |
| FR2754543B1 (fr) | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
-
1999
- 1999-09-02 ID IDW20010900A patent/ID29082A/id unknown
- 1999-09-22 BR BR9914004-7A patent/BR9914004A/pt not_active IP Right Cessation
- 1999-09-22 GE GE4350A patent/GEP20053444B/en unknown
- 1999-09-22 AP APAP/P/2001/002096A patent/AP2010A/en active
- 1999-09-22 DE DE69942393T patent/DE69942393D1/de not_active Expired - Lifetime
- 1999-09-22 CA CA2344173A patent/CA2344173C/en not_active Expired - Fee Related
- 1999-09-22 PL PL348604A patent/PL206260B1/pl not_active IP Right Cessation
- 1999-09-22 HU HU0105391A patent/HUP0105391A3/hu unknown
- 1999-09-22 JP JP2000573707A patent/JP2002526436A/ja active Pending
- 1999-09-22 OA OA1200100075A patent/OA11657A/en unknown
- 1999-09-22 EA EA200100269A patent/EA004797B1/ru not_active IP Right Cessation
- 1999-09-22 IL IL14167599A patent/IL141675A0/xx active IP Right Revival
- 1999-09-22 AU AU60351/99A patent/AU766772B2/en not_active Ceased
- 1999-09-22 CZ CZ20011013A patent/CZ20011013A3/cs unknown
- 1999-09-22 NZ NZ510442A patent/NZ510442A/en not_active IP Right Cessation
- 1999-09-22 AT AT99969329T patent/ATE468108T1/de active
- 1999-09-22 MX MXPA01002973A patent/MXPA01002973A/es not_active IP Right Cessation
- 1999-09-22 KR KR1020017003621A patent/KR100592825B1/ko not_active IP Right Cessation
- 1999-09-22 UA UA2001031606A patent/UA75327C2/uk unknown
- 1999-09-22 CN CNA99811216XA patent/CN1555254A/zh active Pending
- 1999-09-22 EE EEP200100168A patent/EE200100168A/xx unknown
- 1999-09-22 DK DK99969329.4T patent/DK1115382T3/da active
- 1999-09-22 NZ NZ528055A patent/NZ528055A/en not_active IP Right Cessation
- 1999-09-22 EP EP99969329A patent/EP1115382B1/en not_active Expired - Lifetime
- 1999-09-22 WO PCT/US1999/020880 patent/WO2000016746A2/en active IP Right Grant
- 1999-09-22 SK SK322-2001A patent/SK287670B6/sk not_active IP Right Cessation
- 1999-09-22 ES ES99969329T patent/ES2345695T3/es not_active Expired - Lifetime
-
2001
- 2001-02-27 IL IL141675A patent/IL141675A/en not_active IP Right Cessation
- 2001-03-05 ZA ZA200101829A patent/ZA200101829B/en unknown
- 2001-03-20 NO NO20011406A patent/NO330685B1/no not_active IP Right Cessation
- 2001-03-22 BG BG105372A patent/BG65675B1/bg unknown
-
2002
- 2002-01-17 HK HK02100385.1A patent/HK1039064A1/xx not_active IP Right Cessation
-
2010
- 2010-07-30 CY CY20101100715T patent/CY1110718T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101047A3 (en) | Combined vaccine compositions | |
| IL137999A0 (en) | Vaccine compositions | |
| IL138000A0 (en) | Adjuvant compositions | |
| AP2000001874A0 (en) | Cellecoxib compositions | |
| GB9811377D0 (en) | Compositions | |
| EP1154755A4 (en) | Liposomes FORMULATIONS | |
| GB9811457D0 (en) | Rotor | |
| GB9801870D0 (en) | Vaccine composition | |
| HUP0105391A3 (en) | Immunogenic liposome compositions | |
| GB9824075D0 (en) | Rotor | |
| GB2339693B (en) | Anti-mollusc compositions | |
| GB9805782D0 (en) | Compositions | |
| GB0016470D0 (en) | Compositions | |
| GB9812818D0 (en) | Dentfrice compositions | |
| GB9806810D0 (en) | Compositions | |
| GB2336535B (en) | Compositions | |
| GB9809347D0 (en) | Compositions | |
| GB9816050D0 (en) | Compositions | |
| GB9818278D0 (en) | Compositions | |
| GB9806455D0 (en) | Vaccine composition | |
| GB9802879D0 (en) | Vaccine composition | |
| GB9811582D0 (en) | Compositions | |
| GB9805084D0 (en) | Compositions | |
| GB9823750D0 (en) | Compositions | |
| GB9817459D0 (en) | Compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |